| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |